“Beyond 1 million Slides: How the Era of Foundation Models is Super Charging Precision Medicine” - Keynote by Dr. Thomas Fuchs (Thomas J. Fuchs ) July 8, 2024, 10:30am - Hilton, Rochester, MN URL: ai-summit.com #FoundationModels #AI #Medicine #Pathology

Check out Ipek Ensari, PhD, at #HJ24 at the “How AI is revolutionizing cancer detection and care” panel, 6/7 at 4:15 PM! Moderated by journalist Karen Blum, Dr. Ensari joins the discussion alongside other experts on how AI is helping both patients and clinicians in oncology.

Meet Ruchika (Ruchika Verma), PhD, the newest computational scientist to join the Windreich Department of AI and Human Health. Her research focuses on machine learning algorithms to address challenges in evidence-based personalized oncology.

At Mount Sinai Health System millions of slides (pathology ) has been digitized says Thomas J. Fuchs at the #AISummit at Mayo Clinic . Algorithm has been developed to train AI . Paige company has been founded . Extensive work with FDA resulted in approval of the product as a breakthrough

Check out AI and Human Health at Mount Sinai & SinaiMSTP student Emily Leventhal at MD/PhD National Student Conference presenting on 7/12, 2-3pm at the Blue Spruce/Aspen room. She will be presenting her work on mHealth-tracked mental health symptoms and their predictors in chronic pelvic pain patients.

Improved cancer diagnostics could be among the changes #generativeAI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. Learn more in the AI Podcast. blogs.nvidia.com/blog/paige-tho…

A #FoundationModel is just the first step in revolutionizing AI for #pathology. But how can we effectively aggregate thousands of tile embeddings for a whole slide? Thomas J. Fuchs, grad student @GaskellChen & team have a new paper on this. Read on arXiv.org: arxiv.org/abs/2407.07841

How #AI is improving the diagnosis of —rare cancers nature.com/articles/s4159… —rare and ultra-rare diseases nature.com/articles/s4158…

Trained on 1.5 million WSIs from 100,000 patients, a pathology foundation model is shown to improve performance of specialized models in detection of rare cancers Paige Microsoft Research #DigitalPathology #FoundationModel Thomas J. Fuchs nature.com/articles/s4159…

🌟 Introducing Keynote Speaker: Thomas J. Fuchs at #ASDP2024Seoul! 👨🏼‍🏫 We are excited to welcome Thomas Fuchs from Icahn School of Medicine at Mount Sinai, USA, as a keynote speaker for ASDP 2024 Seoul #ASDP #ArtificialIntelligence #Medicine #pathX #pathTwitter

Analysis of histopathology images w/ #AI aims to enable clinical decision support systems & precision medicine but depends on ability to model diverse patterns observed in pathology images. Here, Thomas J. Fuchs, et al. present 'Virchow'! Nature Medicine nature.com/articles/s4159…

We thank Thomas J. Fuchs for his hard work and dedication as Chair of AI and Human Health at Mount Sinai and for advancing AI initiatives through research & collaboration, helping Mount Sinai develop cutting-edge tech to support physicians and aid patients. We wish him luck in his future endeavors.

Thank you Cancer Research for highlighting our work. This collaboration between Memorial Sloan Kettering Cancer Center and Paige showcases how integrating AI and genomics can help discover novel biology. Truly grateful to Jorge Reis-Filho, Thomas J. Fuchs David Klimstra and all the amazing contributors

We’re excited to share our latest work with Paige on (vision) foundation models of pathology. In this study, we introduce Virchow2 and Virchow2G, significantly increasing the scale of our previous work both in terms of data and parameters, with Virchow 2G reaching 1.85B

Paige's new AI module, OmniScreen, is capable of predicting a wide range of clinically relevant molecular biomarkers across multiple cancer types. By replicating a targeted panel of 505 genes, OmniScreen can simultaneously predict 1,228 biomarkers businesswire.com/news/home/2024…

Very proud of this extensive study and the amazing team! It beautifully demonstrates to what #AI is capable in #oncology and how broad the impact on cancer care will be.

Ho Lab is so grateful to host Thomas J. Fuchs at National Cancer Center. We heard his seminar talk entitled “15 Years of Computational Pathology: From Humble Beginnings to Large-Scale Foundation Models” and had many productive discussions with him. Thank you for visiting us!

Eli Lilly recruited Thomas J. Fuchs (NYC-based Paige founder & Dean & dept chair for AI and Human Health at Mount Sinai Health System & Director of HPI.MS) to be their 1st Chief AI Officer. He starts on 10/21 biopharmadive.com/news/lilly-chi… $LLY. Congrats

We would like to once again thank Thomas J. Fuchs for his dedication and leadership as Dean of AI and Human Health, which led to innovative research initiatives and the development and implementation of cutting-edge tech. We wish him the best of luck in his new position.

Thank you Eric Topol for highlighting our work using wearable devices to monitor and predict inflammatory bowel disease flares- an exciting step forward for managing chronic inflammatory conditions using wearable devices! Mount Sinai Division of Gastroenterology Gastroenterology Mount Sinai Department of Medicine Icahn School of Medicine at Mount Sinai